Emerging Growth News
Moberg Pharma AB Interim Report January – March 2019
|
STOCKHOLM, May 14, 2019 /PRNewswire/ -- FIRST QUARTER (JAN-MAR 2019) Net profit after tax SEK 563.9 million (2.0) Total profit for the period SEK 504.5 million (5.6) Diluted earnings per
Emerging Growth News
Andrew Alliance y Arcis Biotechnology anuncian un acuerdo de comarketing
|
- Andrew Alliance anuncia un acuerdo de comarketing con Arcis Biotechnology para ofrecer una solucion manos libres de estabilizacion y preparacion de acido nucleico GINEBRA, 14 de mayo de 2019